Blister Packaging Medication to Increase Treatment Adherence and Clinical Response (BP)
|ClinicalTrials.gov Identifier: NCT01118208|
Recruitment Status : Completed
First Posted : May 6, 2010
Last Update Posted : October 20, 2017
|Condition or disease||Intervention/treatment|
|Medication Adherence Accidental Overdose Deliberate Overdose Suicide, Attempted||Other: Blister packaging medications Other: Dispense as usual|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||303 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Blister Packaging Medication to Increase Treatment Adherence and Clinical Response: Impact on Suicide-Related Morbidity and Mortality|
|Study Start Date :||September 2009|
|Primary Completion Date :||June 2014|
|Study Completion Date :||September 2014|
Experimental: Blister Packaging
Patients will receive all prescription medications on blister pack cards.
Other: Blister packaging medications
Dispensing prescription medications on pre-filled blister package cards.
Other Name: Blister cards, bubble packs, unit-dose packaging.
Active Comparator: Dispense as Usual
Patients will receive all prescription medications in standard pill bottles.
Other: Dispense as usual
Dispensing prescription medications in standard pill bottles.
- Medication Adherence as assessed with the Brief Adherence Rating Scale (BARS) [ Time Frame: monthly for 12 months ]
- Medication overdoses as measured by the Self-Harm Behavior Questionnaire (SHBQ) [ Time Frame: monthly for 12 months ]Both accidental and intentional overdoses will be assessed.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01118208
|United States, Colorado|
|Denver VA Medical Center|
|Denver, Colorado, United States, 80220|
|Principal Investigator:||Peter M Gutierrez, Ph.D.||VA VISN 19 MIRECC|